<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">sibmed</journal-id><journal-title-group><journal-title xml:lang="ru">Сибирский научный медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Сибирский научный медицинский журнал</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2410-2512</issn><issn pub-type="epub">2410-2520</issn><publisher><publisher-name>ИЦиГ СО РАН</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18699/SSMJ20240415</article-id><article-id custom-type="elpub" pub-id-type="custom">sibmed-1623</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL MEDICINE</subject></subj-group></article-categories><title-group><article-title>Прямые и опосредованные связи андрогенного статуса с параметрами эякулята у мужчин из бесплодных пар</article-title><trans-title-group xml:lang="en"><trans-title>Direct and indirect connections of androgen status with ejaculate parameters in men from infertile couples</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9041-2687</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Епанчинцева</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Epanchintseva</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Епанчинцева Елена Александровна, к.м.н.</p><p>630117, г. Новосибирск, ул. Тимакова, 2</p><p>630037, Новосибирск, ул. Кирова, 29 </p><p>630091, г. Новосибирск, Красный пр., 52 </p></bio><bio xml:lang="en"><p>Elena A. Epanchintseva, candidate of medical sciences</p><p>630117, Novosibirsk, Timakova st., 2</p><p>630037, Novosibirsk, Kirova st., 29</p><p>630091, Novosibirsk, Krasny ave., 52</p></bio><email xlink:type="simple">epane@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4534-7289</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Селятицкая</surname><given-names>В. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Selyatitskaya</surname><given-names>V. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Селятицкая Вера Георгиевна, д.б.н., проф.</p><p>630117, г. Новосибирск, ул. Тимакова, 2  </p></bio><bio xml:lang="en"><p>Vera G. Selyatitskaya, doctor of biological sciences, professor</p><p>630117, Novosibirsk, Timakova st., 2</p></bio><email xlink:type="simple">ccem@centercem.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФИЦ фундаментальной и трансляционной медицины; ООО «Новосибирский центр репродуктивной медицины» ГК «Мать и дитя»; Новосибирский государственный медицинский университет Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Research Center of Fundamental And Translational Medicine; LLC “Novosibirsk center of reproductive medicine” of State Company “Mother and child”; Novosibirsk State Medical University of Minzdrav of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФИЦ фундаментальной и трансляционной медицины</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Research Center of Fundamental And Translational Medicine</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>30</day><month>08</month><year>2024</year></pub-date><volume>44</volume><issue>4</issue><fpage>134</fpage><lpage>144</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Епанчинцева Е.А., Селятицкая В.Г., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Епанчинцева Е.А., Селятицкая В.Г.</copyright-holder><copyright-holder xml:lang="en">Epanchintseva E.A., Selyatitskaya V.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://sibmed.elpub.ru/jour/article/view/1623">https://sibmed.elpub.ru/jour/article/view/1623</self-uri><abstract><p>Показано, что у мужчин из бесплодных пар сывороточный уровень общего тестостерона варьирует в широких пределах. Можно ли ожидать, что имеется ассоциация содержания общего тестостерона (Тобщ) сыворотки крови с нарушениями спермограммы у мужчин из бесплодных пар? Цель исследования – изучить закономерности изменения спермиологического статуса мужчин из бесплодных пар в зависимости от уровня Тобщ в крови. Материал и методы. Дизайн – обсервационное ретроспективное одномоментное исследование. Проведен анализ историй болезни 358 мужчин с бесплодием в браке. Выборка разделена на группы сравнения по уровню Тобщ: группа 1 – менее 12,1, группа 2 – от 12,1 до 20,9, группа 3 – 21,0 нмоль/л и более. Результаты. От группы 1 к группе 3 более чем в 2 раза нарастает содержание Тобщ, так же как и концентрация связанных с ним показателей – глобулина, связывающего половые гормоны (ГСПГ), и свободного тестостерона (Тсв). По уровню лютеинизирующего (ЛГ) и фолликулостимулирующего (ФСГ) гормона достоверных различий нет, хотя прослеживается тенденция к его повышению от 1-й к 3-й группе. От группы 1 мужчин с андрогенным дефицитом к группе 3 снижаются не только масса тела и индекс массы тела (ИМТ), но и окружность талии (ОТ) и бедер (ОБ), а также величина индекса ОТ/ ОБ, характеризующего степень абдоминального ожирения. Группы обследованных по величине всех изученных показателей эякулята не различаются. В группе 1 обнаружили выраженную корреляционную связь между содержанием Тобщ и Тсв, в группе 2 и 3 – статистически значимые обратные зависимости уровня Тобщ с величинами антропометрических показателей (массой тела, ИМТ, ОТ и ОБ), а также прямые – с концентрацией ГСПГ, Тсв, ЛГ и эстрадиола, в группе 3 – с уровнем ФСГ. Ни в одной группе обследованных мужчин не выявлено корреляционных связей содержания Тобщ с показателями спермограммы. Заключение. Полученные результаты позволяют говорить о том, что только при высоконормальном уровне тестостерона в крови он может оказывать стимулирующее воздействие на сперматогенез. В результате накопления в популяции случаев андрогенного дефицита прямое позитивное влияние сывороточного тестостерона на сперматогенез становится недостаточным для нормальной регуляции, и на первый план выходит негативное действие дефицита тестостерона на сперматогенез, опосредованное через накопление избыточной массы тела и ожирения.</p></abstract><trans-abstract xml:lang="en"><p>In men from infertile couples the serum level of total testosterone (tT) has been shown to vary widely. Is it possible to expect that there is an association of tT content with spermogram disorders in men from infertile couples? Aim of the study was to investigate the patterns of changes in the spermiological status of men from infertile couples depending on tT level in blood serum. Material and methods. Design – observational, retrospective, one-stage study. The analysis of medical histories of 358 men with infertility in marriage was carried out. The sample was divided into comparison groups according to tT level: group 1 – less than 12.1, group 2 – from 12.1 to 20.9, group 3 – 21.0 nmol/l or more. Results. From group 1 to group 3, tT content increases more than twice, as well as concentration of indicators related to the level of T – sex hormone binding globulin (SHBG) and free testosterone (fT). There are no significant differences in luteinizing hormone (LH) and follicle stimulating hormone (FSH) level, although there is a tendency to its increase from group 1 to group 3. From group 1 of men with androgen deficiency to group 3, not only body weight and body mass index (BMI), but also waist circumference (WC) and hip circumference (HC), as well as the WC/HC index, characterizing the degree of abdominal obesity, decrease. The groups examined did not differ in the values of all studied ejaculate parameters. In group 1, a pronounced correlation between the content of tT and fT was found, in groups 2 and 3 – statistically significant inverse relationships between the level of Tob and the values of anthropometric indicators (body weight, BMI, WC and HC), as well as direct ones - with the concentration of SHBG, tT, LH and estradiol, in group 3 – with FSH levels. There were no correlations between tT content and spermogram indicators in any group of examined men. Conclusions. The results obtained suggest that only at high-normal level of testosterone in the blood it can have a stimulating effect on spermatogenesis. As a result of the accumulation of cases of androgenic deficiency in the population, the direct positive effect of serum testosterone on spermatogenesis is becomes insufficient for normal regulation, and the negative effect of testosterone deficiency on spermatogenesis, mediated through the accumulation of overweight and obesity comes to the fore.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>мужское бесплодие</kwd><kwd>общий тестостерон</kwd><kwd>свободный тестостерон</kwd><kwd>гормоны</kwd><kwd>спермограмма</kwd><kwd>морфология сперматозоидов</kwd><kwd>MAR-тест</kwd><kwd>НВА-тест</kwd><kwd>фрагментация ДНК сперматозоидов</kwd></kwd-group><kwd-group xml:lang="en"><kwd>male infertility</kwd><kwd>total testosterone</kwd><kwd>free testosterone</kwd><kwd>hormones</kwd><kwd>spermogram</kwd><kwd>sperm morphology</kwd><kwd>MAR test</kwd><kwd>HBA test</kwd><kwd>sperm DNA fragmentation</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование проведено в рамках государственного задания ФИЦ ФТМ.</funding-statement><funding-statement xml:lang="en">The study was carried out within the framework of the state assignment of the Federal Research Center of Fundamental and Translational Medicinefor Medical and Technical Medicine.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Eisenberg M.L., Esteves S.C., Lamb D.J., Hotaling J.M., Giwercman A., Hwang K., Cheng Y.-S. Male infertility. Nat. Rev. Dis. Primers. 2023;9(1):49. doi: 10.1038/s41572-023-00459-w</mixed-citation><mixed-citation xml:lang="en">Eisenberg M.L., Esteves S.C., Lamb D.J., Hotaling J.M., Giwercman A., Hwang K., Cheng Y.-S. Male infertility. Nat. Rev. Dis. Primers. 2023;9(1):49. doi: 10.1038/s41572-023-00459-w</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Dutta S., Sengupta P., Muhamad S. Male reproductive hormones and semen quality. Asian. Pac. J. Reprod. 2019;8(5):189–194. doi: 10.4103/2305-0500.268132</mixed-citation><mixed-citation xml:lang="en">Dutta S., Sengupta P., Muhamad S. Male reproductive hormones and semen quality. Asian. Pac. J. Reprod. 2019;8(5):189–194. doi: 10.4103/2305-0500.268132</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Sengupta P., Dutta S., Karkada I.R., Chinni S.V. Endocrinopathies and male infertility. Life (Basel). 2021;12(1):10. doi: 10.3390/life12010010</mixed-citation><mixed-citation xml:lang="en">Sengupta P., Dutta S., Karkada I.R., Chinni S.V. Endocrinopathies and male infertility. Life (Basel). 2021;12(1):10. doi: 10.3390/life12010010</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Shah W., Khan R., Shah B., Khan A., Dil S., Liu W., Wen J., Jiang X. The molecular mechanism of sex hormones on sertoli cell development and proliferation. Front. Endocrinol. (Lausanne). 2021;12:648141. doi: 10.3389/fendo.2021.648141</mixed-citation><mixed-citation xml:lang="en">Shah W., Khan R., Shah B., Khan A., Dil S., Liu W., Wen J., Jiang X. The molecular mechanism of sex hormones on sertoli cell development and proliferation. Front. Endocrinol. (Lausanne). 2021;12:648141. doi: 10.3389/fendo.2021.648141</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Turner T.T., Jones C.E., Howards S.S,. Ewing L.L., Zegeye B., Gunsalus G.L. On the androgen microenvironment of maturing spermatozoa. Endocrinology. 1984;115(5):1925–1932. doi: 10.1210/endo115-5-1925</mixed-citation><mixed-citation xml:lang="en">Turner T.T., Jones C.E., Howards S.S,. Ewing L.L., Zegeye B., Gunsalus G.L. On the androgen microenvironment of maturing spermatozoa. Endocrinology. 1984;115(5):1925–1932. doi: 10.1210/endo115-5-1925</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Huhtaniemi I., Nikula H., Rannikko S. Treatment of prostatic cancer with a gonadotropin-releasing hormone agonist analog: acute and long term effects on endocrine functions of testis tissue. J. Clin. Endocrinol. Metab. 1985;61(4):698–704. doi: 10.1210/jcem-61-4-698</mixed-citation><mixed-citation xml:lang="en">Huhtaniemi I., Nikula H., Rannikko S. Treatment of prostatic cancer with a gonadotropin-releasing hormone agonist analog: acute and long term effects on endocrine functions of testis tissue. J. Clin. Endocrinol. Metab. 1985;61(4):698–704. doi: 10.1210/jcem-61-4-698</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Дедов И.И., Мельниченко Г.А., Роживанов Р.В., Курбатов Д.Г. Рекомендации по диагностике и лечению дефицита тестостерона (гипогонадизма) у мужчин. М., 2016. 19 с. Режим доступа: https://www.endocrincentr.ru/sites/default/files/specialists/science/clinic-recomendations/hypogon.pdf</mixed-citation><mixed-citation xml:lang="en">Dedov I.I., Melnichenko G.A., Rozhivanov R.V., Kurbatov D.G. Recommendations for the diagnosis and treatment of testosterone deficiency (hypogonadism) in men. Moscow, 2016. 19 p. Available at: https://www.endocrincentr.ru/sites/default/files/specialists/science/clinic-recomendations/hypogon.pdf [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Российская ассоциация эндокринологов. Проект клинических рекомендации «Синдром гипогонадизма у мужчин». М., 2021. 32 с. Режим доступа: https://rae-org.ru/system/files/documents/pdf/gipogonadizm_u_muzhchin.pdf</mixed-citation><mixed-citation xml:lang="en">Russian Association of Endocrinologists. Project of clinical recommendations “Hypogonadism syndrome in men”. Moscow, 2021. 32 p. Available at: https://raeorg.ru/system/files/documents/pdf/gipogonadizm_u_muzhchin.pdf [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Пашкова Е.Ю., Рождественская О.А. Возрастной андрогенный дефицит у мужчин: этиология, клиника, диагностика, лечение. Андрол. и генит. хирургия. 2015;16(1):95–101. doi: 10.17650/2070-9781-2015-1-95-101</mixed-citation><mixed-citation xml:lang="en">Pashkova E.Yu., Rozhdestvenskaya O.A. Late-onset hypogonadism: etiology, clinical features, diagnostics, treatment. Andrologiya i genital’naya khirurgiya = Andrology and Genital Surgery. 2015;16(1):95–101. [In Russian]. doi: 10.17650/2070-9781-2015-1-95-101</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Nieschlag E. Late-onset hypogonadism: a concept comes of age. Andrology. 2020;8(6):1506–1511. doi: 10.1111/andr.12719</mixed-citation><mixed-citation xml:lang="en">Nieschlag E. Late-onset hypogonadism: a concept comes of age. Andrology. 2020;8(6):1506–1511. doi: 10.1111/andr.12719</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Park M., Kim S., Won Y. Relationship between testosterone deficiency and the cardiovascular risk factors, diabetes and hypertension. J. Mens Health. 2020;16(4):97–109. doi: 10.31083/jomh.v16i4.328</mixed-citation><mixed-citation xml:lang="en">Park M., Kim S., Won Y. Relationship between testosterone deficiency and the cardiovascular risk factors, diabetes and hypertension. J. Mens Health. 2020;16(4):97–109. doi: 10.31083/jomh.v16i4.328</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Bianchi V.E. Testosterone, myocardial function, and mortality. Heart Fail. Rev. 2018;23(5):773–788. doi: 10.1007/s10741-018-9721-0</mixed-citation><mixed-citation xml:lang="en">Bianchi V.E. Testosterone, myocardial function, and mortality. Heart Fail. Rev. 2018;23(5):773–788. doi: 10.1007/s10741-018-9721-0</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Bieniek J.M., Kashanian J.A., Deibert C.M., Grober E.D., Lo K.C., Brannigan R.E., Sandlow J.I., Jarvi K.A. Influence of increasing body mass index on semen and reproductive hormonal parameters in a multi-institutional cohort of subfertile men. Fertil. Steril. 2016;106(5):1070–1075. doi: 10.1016/j.fertnstert.2016.06.041</mixed-citation><mixed-citation xml:lang="en">Bieniek J.M., Kashanian J.A., Deibert C.M., Grober E.D., Lo K.C., Brannigan R.E., Sandlow J.I., Jarvi K.A. Influence of increasing body mass index on semen and reproductive hormonal parameters in a multi-institutional cohort of subfertile men. Fertil. Steril. 2016;106(5):1070–1075. doi: 10.1016/j.fertnstert.2016.06.041</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Berg W.T., Miner M. Hypogonadism and metabolic syndrome: review and update. Curr. Opin. Endocrinol. Diabetes Obes. 2020;27(6):404–410. doi: 10.1097/MED.0000000000000582</mixed-citation><mixed-citation xml:lang="en">Berg W.T., Miner M. Hypogonadism and metabolic syndrome: review and update. Curr. Opin. Endocrinol. Diabetes Obes. 2020;27(6):404–410. doi: 10.1097/MED.0000000000000582</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Лутов Ю.В., Селятицкая В.Г., Васильева О.В., Пинхасов Б.Б. Взаимоотношения основных факторов патогенеза метаболического синдрома с его компонентами у мужчин. Сиб. науч. мед. ж. 2017;37(6):97–104.</mixed-citation><mixed-citation xml:lang="en">Lutov Yu.V., Selyatitskaya V.G., Vasileva O.V., Pinkhasov B.B. Interaction between main factors of metabolic syndrome pathogenesis and its components in men. Sibirskij nauchnyj medicinskij zhurnal = Siberian Scientific Medical Journal 2017;37(6):97–104. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Villani M.T., Morini D., Spaggiari G., Falbo A.I., Melli B., La Sala G.B., Romeo M., Simoni M., Aguzzoli L., Santiet D. Are sperm parameters able to predict the success of assisted reproductive technology? A retrospective analysis of over 22,000 assisted reproductive technology cycles. Andrology. 2022;10(2):310–321. doi: 10.1111/andr.13123</mixed-citation><mixed-citation xml:lang="en">Villani M.T., Morini D., Spaggiari G., Falbo A.I., Melli B., La Sala G.B., Romeo M., Simoni M., Aguzzoli L., Santiet D. Are sperm parameters able to predict the success of assisted reproductive technology? A retrospective analysis of over 22,000 assisted reproductive technology cycles. Andrology. 2022;10(2):310–321. doi: 10.1111/andr.13123</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Hussein A., Ozgok Y., Ross L., Rao P., Niederberger C. Optimization of spermatogenesis-regulating hormones in patients with non-obstructive azoospermia and its impact on sperm retrieval: a multicentre study. BJU Int. 2013;111(3 Pt B):E110–E114. doi: 10.1111/j.1464-410X.2012.11485.x</mixed-citation><mixed-citation xml:lang="en">Hussein A., Ozgok Y., Ross L., Rao P., Niederberger C. Optimization of spermatogenesis-regulating hormones in patients with non-obstructive azoospermia and its impact on sperm retrieval: a multicentre study. BJU Int. 2013;111(3 Pt B):E110–E114. doi: 10.1111/j.1464-410X.2012.11485.x</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Major N., Edwards K.R., Simpson K., Rogers M. An examination of predictive markers for successful sperm extraction procedures: a linear model and systematic review. Asian J. Androl. 2023;25(1):38–42. doi: 10.4103/aja202221</mixed-citation><mixed-citation xml:lang="en">Major N., Edwards K.R., Simpson K., Rogers M. An examination of predictive markers for successful sperm extraction procedures: a linear model and systematic review. Asian J. Androl. 2023;25(1):38–42. doi: 10.4103/aja202221</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Majzoub A., Arafa M., Clemens H., Imperial J., Leisegang K., Khalafalla K., Agarwal A., Henkel R., Elbardisi H. A systemic review and meta-analysis exploring the predictors of sperm retrieval in patients with non-obstructive azoospermia and chromosomal abnormalities. Andrologia. 2022;54(3):e14303. doi: 10.1111/and.14303</mixed-citation><mixed-citation xml:lang="en">Majzoub A., Arafa M., Clemens H., Imperial J., Leisegang K., Khalafalla K., Agarwal A., Henkel R., Elbardisi H. A systemic review and meta-analysis exploring the predictors of sperm retrieval in patients with non-obstructive azoospermia and chromosomal abnormalities. Andrologia. 2022;54(3):e14303. doi: 10.1111/and.14303</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Епанчинцева Е.А., Янковская С.В., Селятицкая В.Г. Возрастные изменения гормональных показателей андрогенного статуса мужчин из бесплодных пар. Пробл. репродукции. 2021;27(6):125–132. doi: 10.17116/repro202127061125</mixed-citation><mixed-citation xml:lang="en">Epanchintseva E.A., Yankovskaya S.V., Selyatitskaya V.G. Age related hormonal indicators of androgen status of men from infertile couples. Problemy reproduktsii = Russian Journal of Human Reproduction. 2021;27(6):125–132. [In Russian]. doi: 10.17116/repro202127061125</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Руководство ВОЗ по исследованию и обработке эякулята человека. 5-е изд. М.: Капитал принт, 2012. 287 с.</mixed-citation><mixed-citation xml:lang="en">World Health Organization. (‎2010)‎. WHO laboratory manual for the examination and processing of human semen, 5th ed. World Health Organization. Мoscow: Capital print, 2012. 287 p. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Селятицкая В.Г., Епанчинцева Е.А., Новикова Е.Г., Шилина Н.И., Пинхасов Б.Б. Гормональная характеристика андрогенного статуса у мужчин разных возрастных групп. Успехи геронтол. 2019;32(5):737–742.</mixed-citation><mixed-citation xml:lang="en">Selyatitskaya V.G., Epanchintseva E.A., Novikova E.G., Shilina N.I., Pinkhasov B.B. Hormonal feature of the androgen status in different-aged males. Uspekhi gerontologii = Advances in Gerontology. 2019;32(5):737–742. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Tienforti D., Castellini C., di Giulio F., Totaro M., Dalmazio G., Spagnolo L., Muselli M., Corona G., Baroni M.G., Barbonetti A. Selective modulation of estrogen receptor in obese men with androgen deficiency: A systematic review and meta-analysis. Andrology. 2023;11(6):1067–1076. doi: 10.1111/andr.13373</mixed-citation><mixed-citation xml:lang="en">Tienforti D., Castellini C., di Giulio F., Totaro M., Dalmazio G., Spagnolo L., Muselli M., Corona G., Baroni M.G., Barbonetti A. Selective modulation of estrogen receptor in obese men with androgen deficiency: A systematic review and meta-analysis. Andrology. 2023;11(6):1067–1076. doi: 10.1111/andr.13373</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Escobar-Morreale H.F., Santacruz E., LuqueRamírez M., Botella Carretero J.I. Prevalence of ‘obesity-associated gonadal dysfunction’ in severely obese men and women and its resolution after bariatric surgery: a systematic review and meta-analysis. Hum. Reprod. Update. 2017;23(4):390–408. doi: 10.1093/humupd/dmx012</mixed-citation><mixed-citation xml:lang="en">Escobar-Morreale H.F., Santacruz E., LuqueRamírez M., Botella Carretero J.I. Prevalence of ‘obesity-associated gonadal dysfunction’ in severely obese men and women and its resolution after bariatric surgery: a systematic review and meta-analysis. Hum. Reprod. Update. 2017;23(4):390–408. doi: 10.1093/humupd/dmx012</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Епанчинцева Е.А., Селятицкая В.Г., Шеина Ю.И. Параметры эякулята у пациентов с абдоминальным ожирением. Андрол. и генит. хирургия. 2015;16(1):88– 93. doi: 10.17650/2070-9781-2015-1-88-93</mixed-citation><mixed-citation xml:lang="en">Epanchintseva E.A., Selyatitskaya V.G., Sheina Yu.I. Ejaculate parameters in patients with abdominal obesity. Andrologiya i genital’naya khirurgiya = Andrology and Genital Surgery. 2015;16(1):88–93. [In Russian]. doi: 10.17650/2070-9781-2015-1-88-93</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Davidson L.M., Millar K., Jones C., Fatum M., Coward K. Deleterious effects of obesity upon the hormonal and molecular mechanisms controlling spermatogenesis and male fertility. Hum. Fertil. (Camb.). 2015;18(3):184–193. doi: 10.3109/14647273.2015.1070438</mixed-citation><mixed-citation xml:lang="en">Davidson L.M., Millar K., Jones C., Fatum M., Coward K. Deleterious effects of obesity upon the hormonal and molecular mechanisms controlling spermatogenesis and male fertility. Hum. Fertil. (Camb.). 2015;18(3):184–193. doi: 10.3109/14647273.2015.1070438</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Simó R., Sáez-López C., Barbosa-Desongles A., Hernández C., Selva D.M. Novel insights in SHBG regulation and clinical implications. Trends Endocrinol. Metab. 2015;26(7):376–383. doi: 10.1016/j.tem.2015.05.001</mixed-citation><mixed-citation xml:lang="en">Simó R., Sáez-López C., Barbosa-Desongles A., Hernández C., Selva D.M. Novel insights in SHBG regulation and clinical implications. Trends Endocrinol. Metab. 2015;26(7):376–383. doi: 10.1016/j.tem.2015.05.001</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Saboor Aftab S.A., Kumar S., Barber T.M. The role of obesity and type 2 diabetes mellitus in the development of male obesity-associated secondary hypogonadism. Clin. Endocrinol. (Oxf.). 2013;78(3):330– 337. doi: 10.1111/cen.12092</mixed-citation><mixed-citation xml:lang="en">Saboor Aftab S.A., Kumar S., Barber T.M. The role of obesity and type 2 diabetes mellitus in the development of male obesity-associated secondary hypogonadism. Clin. Endocrinol. (Oxf.). 2013;78(3):330– 337. doi: 10.1111/cen.12092</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Xu X., Sun M., Ye J., Luo D., Su X., Zheng D., Feng L., Gao L.,Yu C., Guan Q. The effect of aromatase on the reproductive function of obese males. Horm. Metab. Res. 2017;49(8):572–579. doi: 10.1055/s-0043-107835</mixed-citation><mixed-citation xml:lang="en">Xu X., Sun M., Ye J., Luo D., Su X., Zheng D., Feng L., Gao L.,Yu C., Guan Q. The effect of aromatase on the reproductive function of obese males. Horm. Metab. Res. 2017;49(8):572–579. doi: 10.1055/s-0043-107835</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Porro S., Genchi V.A., Cignarelli A., Natalicchio A., Laviola L., Giorgino F., Perrini S. Dysmetabolic adipose tissue in obesity: morphological and functional characteristics of adipose stem cells and mature adipocytes in healthy and unhealthy obese subjects. J. Endocrinol. Invest. 2021;44(5):921–941. doi: 10.1007/s40618-020-01446-8</mixed-citation><mixed-citation xml:lang="en">Porro S., Genchi V.A., Cignarelli A., Natalicchio A., Laviola L., Giorgino F., Perrini S. Dysmetabolic adipose tissue in obesity: morphological and functional characteristics of adipose stem cells and mature adipocytes in healthy and unhealthy obese subjects. J. Endocrinol. Invest. 2021;44(5):921–941. doi: 10.1007/s40618-020-01446-8</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Childs G.V., Odle A.K., MacNicol M.C., MacNicol A.M. The importance of leptin to reproduction. Endocrinology. 2021;162(2):bqaa204. doi: 10.1210/endocr/bqaa204</mixed-citation><mixed-citation xml:lang="en">Childs G.V., Odle A.K., MacNicol M.C., MacNicol A.M. The importance of leptin to reproduction. Endocrinology. 2021;162(2):bqaa204. doi: 10.1210/endocr/bqaa204</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Lima T.F.N., Nackeeran S., Rakitina E., Lima G.F.N., Arora H., Kargi A.Y., Ramasamy R. Association of leptin with total and free testosterone: results from the national health and nutrition examination surveys. Androg. Clin. Res. Ther. 2020;1(1):94–100. doi: 10.1089/andro.2020.0007</mixed-citation><mixed-citation xml:lang="en">Lima T.F.N., Nackeeran S., Rakitina E., Lima G.F.N., Arora H., Kargi A.Y., Ramasamy R. Association of leptin with total and free testosterone: results from the national health and nutrition examination surveys. Androg. Clin. Res. Ther. 2020;1(1):94–100. doi: 10.1089/andro.2020.0007</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Isidori A.M., Caprio M., Strollo F., Moretti C., Frajese G., Isidori A., Fabbri A. Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels. J. Clin. Endocrinol. Metab. 1999;84(10):3673–3680. doi: 10.1210/jcem.84.10.6082</mixed-citation><mixed-citation xml:lang="en">Isidori A.M., Caprio M., Strollo F., Moretti C., Frajese G., Isidori A., Fabbri A. Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels. J. Clin. Endocrinol. Metab. 1999;84(10):3673–3680. doi: 10.1210/jcem.84.10.6082</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Roychoudhury S., Chakraborty S., Choudhury A.P., Das A., Jha N.K., Slama P., Nath M., Massanyi P., Ruokolainen J., Kesari K.K. Environmental factors-induced oxidative stress: hormonal and molecular pathway disruptions in hypogonadism and erectile dysfunction. Antioxid. (Basel). 2021;10(6):837. doi: 10.3390/antiox10060837</mixed-citation><mixed-citation xml:lang="en">Roychoudhury S., Chakraborty S., Choudhury A.P., Das A., Jha N.K., Slama P., Nath M., Massanyi P., Ruokolainen J., Kesari K.K. Environmental factors-induced oxidative stress: hormonal and molecular pathway disruptions in hypogonadism and erectile dysfunction. Antioxid. (Basel). 2021;10(6):837. doi: 10.3390/antiox10060837</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Spaggiari G., Costantino F., Granata A.R.M., Tagliavini S., Canu G., Varani M., de Santis M.C., Roli L., Trenti T., Simoni M., Santi D. Prolactin and spermatogenesis: new lights on the interplay between prolactin and sperm parameters. Endocrine. 2023;81(2):330–339. doi: 10.1007/s12020-023-03375-x</mixed-citation><mixed-citation xml:lang="en">Spaggiari G., Costantino F., Granata A.R.M., Tagliavini S., Canu G., Varani M., de Santis M.C., Roli L., Trenti T., Simoni M., Santi D. Prolactin and spermatogenesis: new lights on the interplay between prolactin and sperm parameters. Endocrine. 2023;81(2):330–339. doi: 10.1007/s12020-023-03375-x</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Cannarella R., la Vignera S., Condorelli R.A., Mongioì L.M., Calogero A.E. FSH dosage effect on conventional sperm parameters: a meta-analysis of randomized controlled studies. Asian. J. Androl. 2020;22(3):309–316. doi: 10.4103/aja.aja_42_19</mixed-citation><mixed-citation xml:lang="en">Cannarella R., la Vignera S., Condorelli R.A., Mongioì L.M., Calogero A.E. FSH dosage effect on conventional sperm parameters: a meta-analysis of randomized controlled studies. Asian. J. Androl. 2020;22(3):309–316. doi: 10.4103/aja.aja_42_19</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Huijben M., Huijsmans R.L.N., Lock M.T.W.T., de Kemp V.F., de Kort L.M.O., van Breda J.H.M.K. Clomiphene citrate for male infertility: A systematic review and meta-analysis. Andrology. 2023;11(6):987– 996. doi: 10.1111/andr.13388</mixed-citation><mixed-citation xml:lang="en">Huijben M., Huijsmans R.L.N., Lock M.T.W.T., de Kemp V.F., de Kort L.M.O., van Breda J.H.M.K. Clomiphene citrate for male infertility: A systematic review and meta-analysis. Andrology. 2023;11(6):987– 996. doi: 10.1111/andr.13388</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Guo B., Li J.J., Ma Y.L., Zhao Y.T., Liu J.G. Efficacy and safety of letrozole or anastrozole in the treatment of male infertility with low testosterone-estradiol ratio: A meta-analysis and systematic review. Andrology. 2022;10(5):894–909. doi: 10.1111/andr.13185</mixed-citation><mixed-citation xml:lang="en">Guo B., Li J.J., Ma Y.L., Zhao Y.T., Liu J.G. Efficacy and safety of letrozole or anastrozole in the treatment of male infertility with low testosterone-estradiol ratio: A meta-analysis and systematic review. Andrology. 2022;10(5):894–909. doi: 10.1111/andr.13185</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Travison T.G., Araujo A.B., O’Donnell A.B., Kupelian V., McKinlay J.B. A population-level decline in serum testosterone levels in American men. J. Clin. Endocrinol. Metab. 2007;92(1):196–202. doi: 10.1210/jc.2006-1375</mixed-citation><mixed-citation xml:lang="en">Travison T.G., Araujo A.B., O’Donnell A.B., Kupelian V., McKinlay J.B. A population-level decline in serum testosterone levels in American men. J. Clin. Endocrinol. Metab. 2007;92(1):196–202. doi: 10.1210/jc.2006-1375</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Perheentupa A., Mäkinen J., Laatikainen T., Vierula M., Skakkebaek N.E., Andersson A.-M., Toppari J. A cohort effect on serum testosterone levels in Finnish men. Eur. J. Endocrinol. 2013;168(2):227–233. doi: 10.1530/EJE-12-0288</mixed-citation><mixed-citation xml:lang="en">Perheentupa A., Mäkinen J., Laatikainen T., Vierula M., Skakkebaek N.E., Andersson A.-M., Toppari J. A cohort effect on serum testosterone levels in Finnish men. Eur. J. Endocrinol. 2013;168(2):227–233. doi: 10.1530/EJE-12-0288</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
